Free Trial

Avantor (AVTR) Competitors

Avantor logo
$9.12 -0.01 (-0.05%)
Closing price 05/29/2026 03:59 PM Eastern
Extended Trading
$9.13 +0.02 (+0.18%)
As of 05:52 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

AVTR vs. A, DHR, RVTY, TMO, and VLTO

Should you buy Avantor stock or one of its competitors? MarketBeat compares Avantor with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Avantor include Agilent Technologies (A), Danaher (DHR), Revvity (RVTY), Thermo Fisher Scientific (TMO), and Veralto (VLTO).

How does Avantor compare to Agilent Technologies?

Avantor (NYSE:AVTR) and Agilent Technologies (NYSE:A) are both medical companies, but which is the better investment? We will compare the two businesses based on the strength of their media sentiment, earnings, analyst recommendations, dividends, valuation, institutional ownership, profitability and risk.

Agilent Technologies has a net margin of 19.55% compared to Avantor's net margin of -8.42%. Agilent Technologies' return on equity of 24.33% beat Avantor's return on equity.

Company Net Margins Return on Equity Return on Assets
Avantor-8.42% 9.95% 4.78%
Agilent Technologies 19.55%24.33%12.99%

Avantor currently has a consensus target price of $10.82, indicating a potential upside of 18.72%. Agilent Technologies has a consensus target price of $162.79, indicating a potential upside of 20.24%. Given Agilent Technologies' stronger consensus rating and higher probable upside, analysts plainly believe Agilent Technologies is more favorable than Avantor.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Avantor
2 Sell rating(s)
11 Hold rating(s)
2 Buy rating(s)
0 Strong Buy rating(s)
2.00
Agilent Technologies
0 Sell rating(s)
1 Hold rating(s)
12 Buy rating(s)
2 Strong Buy rating(s)
3.07

Avantor has a beta of 0.97, meaning that its share price is 3% less volatile than the broader market. Comparatively, Agilent Technologies has a beta of 1.26, meaning that its share price is 26% more volatile than the broader market.

95.1% of Avantor shares are held by institutional investors. 0.3% of Avantor shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.

In the previous week, Agilent Technologies had 42 more articles in the media than Avantor. MarketBeat recorded 46 mentions for Agilent Technologies and 4 mentions for Avantor. Agilent Technologies' average media sentiment score of 0.84 beat Avantor's score of 0.83 indicating that Agilent Technologies is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Avantor
2 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
1 Negative mention(s)
0 Very Negative mention(s)
Positive
Agilent Technologies
18 Very Positive mention(s)
8 Positive mention(s)
10 Neutral mention(s)
0 Negative mention(s)
1 Very Negative mention(s)
Positive

Agilent Technologies has higher revenue and earnings than Avantor. Avantor is trading at a lower price-to-earnings ratio than Agilent Technologies, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Avantor$6.55B0.95-$530.20M-$0.81N/A
Agilent Technologies$6.95B5.51$1.30B$4.9827.19

Summary

Agilent Technologies beats Avantor on 15 of the 17 factors compared between the two stocks.

How does Avantor compare to Danaher?

Danaher (NYSE:DHR) and Avantor (NYSE:AVTR) are both medical companies, but which is the better investment? We will contrast the two companies based on the strength of their institutional ownership, media sentiment, valuation, earnings, analyst recommendations, profitability, risk and dividends.

Danaher presently has a consensus price target of $238.24, suggesting a potential upside of 30.38%. Avantor has a consensus price target of $10.82, suggesting a potential upside of 18.72%. Given Danaher's stronger consensus rating and higher possible upside, research analysts clearly believe Danaher is more favorable than Avantor.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Danaher
0 Sell rating(s)
3 Hold rating(s)
20 Buy rating(s)
0 Strong Buy rating(s)
2.87
Avantor
2 Sell rating(s)
11 Hold rating(s)
2 Buy rating(s)
0 Strong Buy rating(s)
2.00

Danaher has a net margin of 14.89% compared to Avantor's net margin of -8.42%. Danaher's return on equity of 10.91% beat Avantor's return on equity.

Company Net Margins Return on Equity Return on Assets
Danaher14.89% 10.91% 6.94%
Avantor -8.42%9.95%4.78%

In the previous week, Danaher had 5 more articles in the media than Avantor. MarketBeat recorded 9 mentions for Danaher and 4 mentions for Avantor. Danaher's average media sentiment score of 1.00 beat Avantor's score of 0.83 indicating that Danaher is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Danaher
4 Very Positive mention(s)
0 Positive mention(s)
4 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Avantor
2 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
1 Negative mention(s)
0 Very Negative mention(s)
Positive

Danaher has higher revenue and earnings than Avantor. Avantor is trading at a lower price-to-earnings ratio than Danaher, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Danaher$24.57B5.26$3.61B$5.1735.34
Avantor$6.55B0.95-$530.20M-$0.81N/A

79.1% of Danaher shares are held by institutional investors. Comparatively, 95.1% of Avantor shares are held by institutional investors. 10.8% of Danaher shares are held by insiders. Comparatively, 0.3% of Avantor shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.

Danaher has a beta of 0.81, meaning that its stock price is 19% less volatile than the broader market. Comparatively, Avantor has a beta of 0.97, meaning that its stock price is 3% less volatile than the broader market.

Summary

Danaher beats Avantor on 14 of the 16 factors compared between the two stocks.

How does Avantor compare to Revvity?

Revvity (NYSE:RVTY) and Avantor (NYSE:AVTR) are both medical companies, but which is the superior stock? We will contrast the two companies based on the strength of their profitability, dividends, earnings, risk, media sentiment, valuation, analyst recommendations and institutional ownership.

86.7% of Revvity shares are held by institutional investors. Comparatively, 95.1% of Avantor shares are held by institutional investors. 0.9% of Revvity shares are held by insiders. Comparatively, 0.3% of Avantor shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth.

Revvity has a beta of 1.11, meaning that its stock price is 11% more volatile than the broader market. Comparatively, Avantor has a beta of 0.97, meaning that its stock price is 3% less volatile than the broader market.

Revvity currently has a consensus price target of $107.73, indicating a potential upside of 2.71%. Avantor has a consensus price target of $10.82, indicating a potential upside of 18.72%. Given Avantor's higher possible upside, analysts plainly believe Avantor is more favorable than Revvity.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Revvity
1 Sell rating(s)
8 Hold rating(s)
4 Buy rating(s)
0 Strong Buy rating(s)
2.23
Avantor
2 Sell rating(s)
11 Hold rating(s)
2 Buy rating(s)
0 Strong Buy rating(s)
2.00

Revvity has a net margin of 8.26% compared to Avantor's net margin of -8.42%. Avantor's return on equity of 9.95% beat Revvity's return on equity.

Company Net Margins Return on Equity Return on Assets
Revvity8.26% 8.00% 4.83%
Avantor -8.42%9.95%4.78%

In the previous week, Revvity had 9 more articles in the media than Avantor. MarketBeat recorded 13 mentions for Revvity and 4 mentions for Avantor. Avantor's average media sentiment score of 0.83 beat Revvity's score of -0.08 indicating that Avantor is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Revvity
0 Very Positive mention(s)
0 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral
Avantor
2 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
1 Negative mention(s)
0 Very Negative mention(s)
Positive

Revvity has higher earnings, but lower revenue than Avantor. Avantor is trading at a lower price-to-earnings ratio than Revvity, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Revvity$2.86B4.10$241.20M$2.0950.18
Avantor$6.55B0.95-$530.20M-$0.81N/A

Summary

Revvity beats Avantor on 11 of the 16 factors compared between the two stocks.

How does Avantor compare to Thermo Fisher Scientific?

Avantor (NYSE:AVTR) and Thermo Fisher Scientific (NYSE:TMO) are both medical companies, but which is the better investment? We will contrast the two companies based on the strength of their dividends, valuation, profitability, institutional ownership, risk, analyst recommendations, earnings and media sentiment.

95.1% of Avantor shares are held by institutional investors. Comparatively, 89.2% of Thermo Fisher Scientific shares are held by institutional investors. 0.3% of Avantor shares are held by insiders. Comparatively, 0.3% of Thermo Fisher Scientific shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth.

Avantor presently has a consensus price target of $10.82, suggesting a potential upside of 18.72%. Thermo Fisher Scientific has a consensus price target of $616.10, suggesting a potential upside of 25.14%. Given Thermo Fisher Scientific's stronger consensus rating and higher possible upside, analysts clearly believe Thermo Fisher Scientific is more favorable than Avantor.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Avantor
2 Sell rating(s)
11 Hold rating(s)
2 Buy rating(s)
0 Strong Buy rating(s)
2.00
Thermo Fisher Scientific
0 Sell rating(s)
3 Hold rating(s)
18 Buy rating(s)
2 Strong Buy rating(s)
2.96

In the previous week, Thermo Fisher Scientific had 32 more articles in the media than Avantor. MarketBeat recorded 36 mentions for Thermo Fisher Scientific and 4 mentions for Avantor. Thermo Fisher Scientific's average media sentiment score of 1.29 beat Avantor's score of 0.83 indicating that Thermo Fisher Scientific is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Avantor
2 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
1 Negative mention(s)
0 Very Negative mention(s)
Positive
Thermo Fisher Scientific
27 Very Positive mention(s)
4 Positive mention(s)
3 Neutral mention(s)
2 Negative mention(s)
0 Very Negative mention(s)
Positive

Thermo Fisher Scientific has a net margin of 15.15% compared to Avantor's net margin of -8.42%. Thermo Fisher Scientific's return on equity of 16.86% beat Avantor's return on equity.

Company Net Margins Return on Equity Return on Assets
Avantor-8.42% 9.95% 4.78%
Thermo Fisher Scientific 15.15%16.86%8.15%

Avantor has a beta of 0.97, suggesting that its stock price is 3% less volatile than the broader market. Comparatively, Thermo Fisher Scientific has a beta of 0.88, suggesting that its stock price is 12% less volatile than the broader market.

Thermo Fisher Scientific has higher revenue and earnings than Avantor. Avantor is trading at a lower price-to-earnings ratio than Thermo Fisher Scientific, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Avantor$6.55B0.95-$530.20M-$0.81N/A
Thermo Fisher Scientific$44.56B4.11$6.70B$18.1927.07

Summary

Thermo Fisher Scientific beats Avantor on 15 of the 17 factors compared between the two stocks.

How does Avantor compare to Veralto?

Veralto (NYSE:VLTO) and Avantor (NYSE:AVTR) are both measuring and control equipment companies, but which is the superior stock? We will contrast the two companies based on the strength of their analyst recommendations, institutional ownership, dividends, risk, earnings, profitability, media sentiment and valuation.

91.3% of Veralto shares are owned by institutional investors. Comparatively, 95.1% of Avantor shares are owned by institutional investors. 0.4% of Veralto shares are owned by company insiders. Comparatively, 0.3% of Avantor shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.

In the previous week, Veralto and Veralto both had 4 articles in the media. Avantor's average media sentiment score of 0.83 beat Veralto's score of -0.10 indicating that Avantor is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Veralto
1 Very Positive mention(s)
1 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral
Avantor
2 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
1 Negative mention(s)
0 Very Negative mention(s)
Positive

Veralto has a net margin of 17.33% compared to Avantor's net margin of -8.42%. Veralto's return on equity of 34.63% beat Avantor's return on equity.

Company Net Margins Return on Equity Return on Assets
Veralto17.33% 34.63% 13.44%
Avantor -8.42%9.95%4.78%

Veralto presently has a consensus target price of $105.88, indicating a potential upside of 28.67%. Avantor has a consensus target price of $10.82, indicating a potential upside of 18.72%. Given Veralto's stronger consensus rating and higher possible upside, research analysts clearly believe Veralto is more favorable than Avantor.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Veralto
0 Sell rating(s)
6 Hold rating(s)
5 Buy rating(s)
0 Strong Buy rating(s)
2.45
Avantor
2 Sell rating(s)
11 Hold rating(s)
2 Buy rating(s)
0 Strong Buy rating(s)
2.00

Veralto has a beta of 0.7, indicating that its share price is 30% less volatile than the broader market. Comparatively, Avantor has a beta of 0.97, indicating that its share price is 3% less volatile than the broader market.

Veralto has higher earnings, but lower revenue than Avantor. Avantor is trading at a lower price-to-earnings ratio than Veralto, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Veralto$5.50B3.67$940M$3.8721.26
Avantor$6.55B0.95-$530.20M-$0.81N/A

Summary

Veralto beats Avantor on 11 of the 15 factors compared between the two stocks.

Get Avantor News Delivered to You Automatically

Sign up to receive the latest news and ratings for AVTR and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding AVTR and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

AVTR vs. The Competition

MetricAvantorMedical Services IndustryMedical SectorNYSE Exchange
Market Cap$6.22B$8.52B$6.40B$23.18B
Dividend YieldN/A1.76%2.68%4.09%
P/E Ratio-11.2521.9921.5930.62
Price / Sales0.9519.93551.7424.75
Price / Cash6.0212.8927.4419.43
Price / Book1.125.1310.044.70
Net Income-$530.20M$175.77M$3.56B$1.07B
7 Day Performance12.46%2.88%2.83%1.14%
1 Month PerformanceN/AN/AN/A1.58%
1 Year Performance-29.40%5.69%37.61%28.06%

Avantor Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
AVTR
Avantor
3.1417 of 5 stars
$9.12
-0.1%
$10.82
+18.7%
-29.4%$6.22B$6.55BN/A13,500
A
Agilent Technologies
4.8097 of 5 stars
$115.01
+0.0%
$163.71
+42.4%
+21.1%$32.49B$6.95B25.3918,100
DHR
Danaher
4.6885 of 5 stars
$172.12
+0.1%
$238.65
+38.7%
-3.6%$121.74B$24.57B33.2960,000
RVTY
Revvity
2.065 of 5 stars
$96.93
0.0%
$107.73
+11.1%
+16.0%$10.82B$2.86B46.3811,000
TMO
Thermo Fisher Scientific
4.9069 of 5 stars
$448.55
+0.1%
$616.10
+37.4%
+22.3%$166.59B$44.56B24.66125,000

Related Companies and Tools


This page (NYSE:AVTR) was last updated on 6/1/2026 by MarketBeat.com Staff.
From Our Partners